GROUP ONE TRADING, L.P. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 17 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$53,000
-11.7%
11,460
+93.2%
0.00%
Q3 2018$60,000
-1.6%
5,931
-30.1%
0.00%
-100.0%
Q2 2018$61,000
-51.6%
8,486
-40.2%
0.00%0.0%
Q3 2017$126,000
-55.9%
14,196
-20.6%
0.00%
-75.0%
Q1 2016$286,000
+61.6%
17,882
+318.3%
0.00%
+33.3%
Q1 2014$177,000
+185.5%
4,275
+167.2%
0.00%
+200.0%
Q4 2013$62,0001,6000.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2019
NameSharesValueWeighting ↓
ADVANTAGE INVESTMENT MANAGEMENT, LLC 105$00.00%
Sterling Investment Advisors, Ltd. 250$00.00%
Front Row Advisors LLC 60$00.00%
Executive Wealth Management, LLC 20$00.00%
BARCLAYS PLC 1,300$00.00%
BARCLAYS PLC 33,172$10,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Financial Gravity Asset Management, Inc. 50$00.00%
Vectors Research Management, LLC 505$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders